Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metformin With a Carbohydrate Restricted Diet In Combination With Platinum Based Chemotherapy In Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NS-NSCLC) - METRO Study

NCT02019979 is registered in ClinicalTrials.gov with Beth Israel Medical Center as lead sponsor.

NCT NCT02019979
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02019979 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metformin With a Carbohydrate Restricted Diet In Combination With Platinum Based Chemotherapy In Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NS-NSCLC) - METRO Study
Lead sponsor
Beth Israel Medical Center
Phase
Phase 2
Overall status
Terminated
Start date
December 31, 2013
Completion date
December 31, 2016
Enrollment
14 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer metastatic, non-small cell lung cancer stage iiib/iv, nonsquamous nonsmall cell neoplasm of lung